Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2010
08/26/2010US20100216808 Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
08/26/2010US20100216790 Imidazopyridine-derivatives as inducible no-synthase inhibitors
08/26/2010US20100216774 Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
08/26/2010US20100216773 Phenanthroindolizidine analogues
08/26/2010US20100216761 Novel azetidinones useful as inhibitors of elastase
08/26/2010US20100216746 Chemical compounds
08/26/2010US20100216745 Novel cephem compounds useful for the treatment of bacterial infections
08/26/2010US20100216739 Method of promoting muscle tissue repair
08/26/2010US20100216731 Process for the preparation of macrolide antibacterial agents
08/26/2010US20100216725 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
08/26/2010US20100216724 Use of fibronectin fragment (196-203 ) as a therapeutic agent
08/26/2010US20100216722 Use of the peptide pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys as a therapeutic agent
08/26/2010US20100216711 Protease-Stable, Cell Wall-Lysing Enzymes
08/26/2010US20100216699 Semi-synthetic glycopeptides having antibacterial activity
08/26/2010US20100216698 Liquid formulations of g-csf
08/26/2010US20100216697 Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
08/26/2010US20100216689 Cytotoxic t cell activator comprising ep4 agonist
08/26/2010US20100215787 Composition For The Treatment Of Gastrointestinal Diseases
08/26/2010US20100215760 Intrinscially fluorescent carbon nanospheres and a process thereof
08/26/2010US20100215756 Pharmaceutical preparations containing highly volatile silicones
08/26/2010US20100215708 Coating of devices with effector compounds
08/26/2010US20100215699 Lactoferrin as a radioprotective agent
08/26/2010US20100215696 Efficiently replicable heptitis c virus mutant, a heptitis c virus mutant comprising reporter gene, a method of preparing of hcv vaccine using the same and a method of screening anti hcv composition using the same
08/26/2010US20100215693 Immunological herpes simplex virus antigens and methods for use thereof
08/26/2010US20100215692 Dengue Chimeric Viruses
08/26/2010US20100215691 Recombinant viral vectors
08/26/2010US20100215686 Process for Manufacturing Vaccines
08/26/2010US20100215685 Acyl pseudodipeptides which carry a functionalized auxiliary arm
08/26/2010US20100215684 Streptococcus m protein, immunogenic fragments, nucleic acids and methods of use
08/26/2010US20100215683 Protective antigens for group b streptococcus hypervirulent strains
08/26/2010US20100215682 Deletion of the beta 20-21 loop in hiv gp120 exposes the cd4 binding site for improved antibody binding and antibody induction
08/26/2010US20100215681 Fusion proteins comprising hiv-1 tat and/or nef proteins
08/26/2010US20100215680 Replikin peptides and antibodies therefor
08/26/2010US20100215679 Methods and compositions for treating tularemia
08/26/2010US20100215675 Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
08/26/2010US20100215674 Enhancing the t-cells stimulatory capacity of human antigen presenting cells and their use in vaccination
08/26/2010US20100215664 Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6 -mediated signalling
08/26/2010US20100215662 Anti-influenza M2e antibody
08/26/2010US20100215661 Nicotinamide derivates useful as p38 inhibitors
08/26/2010US20100215658 Vaccinia virus h3l and b5r specific monoclonal antibodies and methods of making and using same
08/26/2010US20100215652 Nicotinamide derivates useful as p38 inhibitors
08/26/2010US20100215649 Antibodies for norovirus
08/26/2010US20100215642 Synthetic rna-based agonists of tlr7
08/26/2010US20100215620 The co-culture method of sphingomonas sp. bacterial strain and aspergillus sp. fungus strain, new anti-cancer and antibiotic glionitrins derived from this co-culture method, and pharmaceutical composition containing glionitrins or pharmaceutically acceptable salt thereof as an active ingredient
08/26/2010US20100215616 Hepatitis C Virus Inhibitors
08/26/2010US20100215614 Enterostatin as Inhibitor of Angiogenesis
08/26/2010US20100215591 Antimicrobial peptide, compositions, and methods of use
08/26/2010US20100215574 Process for producing an injectable medicament preparation
08/26/2010US20100215572 Methods of treatment using ldcam
08/26/2010DE102009008919A1 Behandlungslösung für die Behandlung von Wunden, insbesondere für die liquide Wundbehandlung Treatment solution for the treatment of wounds, in particular for the liquid treatment of wounds
08/26/2010CA2786891A1 Immunopotentiating composition and process for producing same
08/26/2010CA2753280A1 Anti-human .alpha.9 integrin antibody and use thereof
08/26/2010CA2752579A1 Hepatitis c virus inhibitors
08/26/2010CA2752373A1 Glutathione-based drug delivery system
08/26/2010CA2750993A1 Carboxamide compounds and their use as calpain inhibitors
08/25/2010EP2221377A1 Oligonucleotide compositions with enhanced efficiency
08/25/2010EP2221309A1 Novel naphthyridine derivative monohydrate and method for producing the same
08/25/2010EP2221062A1 Novel adjuvant
08/25/2010EP2221061A1 Antimicrobial peptides derived from CAP18
08/25/2010EP2221047A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
08/25/2010EP2220116A1 Compositions and methods for the therapy and diagnosis of influenza
08/25/2010EP2220095A1 Inhibitors of human immunodeficiency virus replication
08/25/2010EP2220091A2 Reverse transcriptase inhibitors
08/25/2010EP2220084A1 Inhibitors of human immunodeficiency virus replication
08/25/2010EP2220076A1 Inhibitors of human immunodeficiency virus replication
08/25/2010EP2220062A1 New human papilloma virus inhibitors and pharmaceutical compositions containing same
08/25/2010EP2220046A1 Inhibitors of human immunodeficiency virus replication
08/25/2010EP2220037A1 Synthetic sphingolipid analogs
08/25/2010EP2220033A1 Crystalline forms of tigecycline hydrochloride
08/25/2010EP2220032A1 Novel solvate
08/25/2010EP2219655A2 Methods of treating or preventing inflammatory diseases of the intestinal tract
08/25/2010EP2219642A1 Silibinin component for the treatment of hepatitis
08/25/2010EP2219631A1 Use of anti-bacterial compounds having an anaesthetic effect
08/25/2010EP2047855B1 Anti-tumoral, antibacterial and antiviral pharmaceutical composition (variants)
08/25/2010EP1879884B1 Azole-based phosphodiesterase inhibitors
08/25/2010EP1658302B1 Purine nucleoside analogues for treating diseases caused by flaviviridae including hepatitis c
08/25/2010EP1482791B1 Antimicrobial therapeutic compositions and methods of use
08/25/2010EP1469882B1 Treatment of nervous system diseases with goat serum
08/25/2010EP1404367B1 Use of polyclonal anti-hiv goat serum as a therapeutic agent
08/25/2010EP1363632B1 Receptor selective cannabimimetic aminoalkylindoles
08/25/2010EP1339738B1 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
08/25/2010EP1339402B1 Azaphenanthridone derivatives and their use as parp inhibitors
08/25/2010EP1194580B2 In vitro reconstitution of segmented negative-strand rna viruses
08/25/2010EP1181047B9 Composition comprising alkaline sphingomyelinase of bacterial origin for use as a dietetic preparation, food supplement or pharmaceutical product
08/25/2010EP1042286B1 Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith
08/25/2010CN201558397U Sustained-releasing amikacin carrying catheter
08/25/2010CN201558345U Health care sachet
08/25/2010CN1994364B Subprostrate soplhor root extract refining process
08/25/2010CN1980909B Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
08/25/2010CN1969876B Lyophilized injection of lentinan and preparation process thereof
08/25/2010CN1951411B Nitric oxide and its biomedical significance
08/25/2010CN1872318B Drop pills of oil of zedoary turmeric, and preparation method
08/25/2010CN1827766B In vitro cell cultivation method
08/25/2010CN101815533A Combination therapy for the treatment of HCV infection
08/25/2010CN101815529A Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
08/25/2010CN101815511A anti-bacterial pyrocatechols and related methods
08/25/2010CN101812473A Human papillomavirus and chlamydia trachomatis chimeric nucleic acid vaccine and applications thereof
08/25/2010CN101812468A Method for preparing rabies virus antigen by chloroplast
08/25/2010CN101812464A New functions and applications of mycobacterium tuberculosis WhiB3 gene
08/25/2010CN101812438A Arginine deiminase mutant and preparation and application thereof
1 ... 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 ... 1798